CDKN2A and breast carcinoma: Available data from previously published studies were pooled and analyzed (Supplementary Table 2, and Supplementary Excel Files 1 and 2), but the data did not show any association between CDKN2A expression level in primary breast cancers and the risk of brain metastases (p = 0.16).